The Drug Enforcement Administration (DEA) is again greatly increasing legal production quotas for illegal Schedule I drugs like psilocybin, MDMA and DMT.
After releasing its initial goals for the psychedelics to be produced for research purposes in the U.S. for 2021 earlier this year, DEA put forward boosted numbers in September and then opened a public comment period. The agency took that feedback into consideration and assessed scientific demands before landing on the final quotas, which are even higher than the figures from two months ago.
Separately, DEA also recently proposed increased quotas for the production of these substances for research purposes in 2022.
Read More
DEA Boosts Psilocybin, MDMA And DMT Production Levels Again In Final Quotas For 2021
